Product Information
FLUOXETINE HCL 20 MG CAPSULE is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0293 per EA under NDC 69367023610. Its NADAC has been published 351 times since Jan 15, 2020.
FDA first approved this application on Mar 16, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367023610
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204597FDA Approved
3/16/2015
TE Code
AB1
On Market Since
9/25/2019
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 20 MG CAPSULE has been published 351 times since Jan 15, 2020, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0293 per EA |
|---|---|
| All-time high | $0.0348 (Nov 16, 2022) |
| All-time low | $0.0275 (May 22, 2024) |
| 52-week high | $0.0301 |
| 52-week low | $0.0289 |
| Median price | $0.0309 |
| Average price | $0.0311 |
| Largest weekly change | -13.9% (Nov 20, 2024) |
| Weeks tracked | 351 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 20 MG CAPSULE, manufactured by Westminster Pharmaceuticals LLC, is $0.0293 per EA (NDC 69367023610), effective Sep 30, 2026.
How has the price of FLUOXETINE HCL 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 20 MG CAPSULE has declined 3.2%. It has been tracked across 351 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 20 MG CAPSULE?
Since Jan 15, 2020, the NADAC for FLUOXETINE HCL 20 MG CAPSULE has ranged from a low of $0.0275 (May 22, 2024) to a high of $0.0348 (Nov 16, 2022), with a median of $0.0309 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 20 MG CAPSULE?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 20 MG CAPSULE?
FLUOXETINE HCL 20 MG CAPSULE (NDC 69367023610) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.